University of California San Francisco School of Medicine: Transplantation
Welcome,         Profile    Billing    Logout  
 11 Trials 
16 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vincenti, Flavio
TASK, NCT02711826: Treg Therapy in Subclinical Inflammation in Kidney Transplantation

Completed
1/2
32
US
Polyclonal Regulatory T Cells, Polyclonal Tregs, polyTregs, Everolimus, Zortress, Tacrolimus, FK-506, FR-900506, Prograf, Mycophenolate mofetil, Cellcept, MMF, Mycophenolic acid, Myfortic, MPA, Acetaminophen, Tylenol, Diphenhydramine, Benadryl, Biopsy, Kidney, Kidney Biopsy, Blood Draw, Phlebotomy, Venipuncture, Leukapheresis, leukocytapheresis, IS regimen conversion, Everolimus Conversion
National Institute of Allergy and Infectious Diseases (NIAID), Clinical Trials in Organ Transplantation
Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant, Living Kidney Donor
08/23
08/23
NCT04066114: Treg Modulation With CD28 and IL-6 Receptor Antagonists

Completed
1/2
24
US
lulizumab pegol, BMS-931699, antithymocyte globulin (rabbit), ATG (rabbit), Thymoglobulin®, methylprednisolone, Solu-Medrol ®, tocilizumab, Actemra®, Prednisone, prednisone tablets, Rayos®, everolimus, Zortress®, belatacept, Nulojix®, mycophenolate mofetil, MMF, CellCept®, mycophenolic acid, Myfortic®
National Institute of Allergy and Infectious Diseases (NIAID), Bristol-Myers Squibb, Clinical Trials in Organ Transplantation
Living-Donor Kidney Transplant, Kidney Transplant Recipients
09/23
09/23
ATTAIN, NCT04827979: Daratumumab and Belatacept for Desensitization

Recruiting
1/2
15
US
daratumumab, Darzalex®, immunoglobulin G1 kappa human monoclonal antibody, IgG1k human mAb, belatacept, Nulojix®, Bone marrow aspiration
National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN), Bristol-Myers Squibb, PPD, Rho Federal Systems Division, Inc.
Highly Sensitized Prospective Kidney Transplant Recipients
03/27
04/28
Chen, Chun Chung
NCT04009265: Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma

Recruiting
3
819
RoW
adjuvant treatment
Fujian Medical University Union Hospital
Esophageal Squamous Cell Carcinoma
07/22
07/27
POINT, NCT04513418: Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy

Recruiting
3
244
RoW
Preoperative immunonutrition
Hecheng Li M.D., Ph.D, Shanghai Chest Hospital, Shanghai Zhongshan Hospital, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University, Ningbo Medical Center Lihuili Hospital, Zhejiang Cancer Hospital, Fujian Medical University Union Hospital, Shanghai East Hospital
Esophageal Neoplasms
03/25
12/28
NCT05930210: A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

Recruiting
3
230
US, RoW
ENERGI-F703 GEL, ENERGI-F703 matched vehicle
Energenesis Biomedical Co., Ltd.
Diabetic Foot Ulcer, Foot Ulcer, Diabetes Mellitus, Wound
09/25
12/25
TERMGGO, NCT04982900: Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities

Recruiting
2
138
RoW
furmonertinib, AST2818, Placebo
Ruijin Hospital, Fujian Medical University Union Hospital, First Affiliated Hospital of Zhejiang University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Tang-Du Hospital, The First Affiliated Hospital of Nanchang University
Multiple Primary Lung Cancers
08/22
08/22
NCT05821452: Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma

Not yet recruiting
2
40
RoW
Camrelizumab, pdl1 Inhibitors, Paclitaxel, Paclitaxel For Injection (Albumin Bound), Cisplatin, Radiotherapy, Radiation therapy
Fujian Medical University Union Hospital
Chemotherapy, Radiation Therapy
05/24
05/26
NCT05176002: Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.

Recruiting
1/2
26
RoW
Camrelizumab
Fujian Medical University Union Hospital
Esophageal Neoplasm, Immunotherapy, Radiotherapy
09/23
09/24
NCT06474078: Study To Evaluate The Efficacy Of Tofacitinib In Patients With SJS/TEN

Recruiting
N/A
20
RoW
Tofacitinib, XELJANZ
Chang Gung Memorial Hospital
Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis
07/25
07/25
NCT04615806: The Value of Lymph Node Dissection of Indocyanine Green-guided Near-infrared Fluorescent Imaging in Esophagectomy

Recruiting
N/A
40
RoW
Indocyanine green solution, Indocyanine Green for Injection
Fujian Medical University Union Hospital
Esophageal Cancer, Indocyanine Green
09/22
09/23
NCT05593224: The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Intracranial Atherosclerotic Stenosis

Not yet recruiting
N/A
156
RoW
Intracranial Stent (Tonbridge)
Zhuhai Tonbridge Medical Tech. Co., Ltd.
Intracranial Atherosclerosis
11/23
05/25
NCT05757505: The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis

Recruiting
N/A
200
RoW
Intracranial Stent (Tonbridge), Wingspan Stent System (Stryker Neurovascular)
Zhuhai Tonbridge Medical Tech. Co., Ltd.
Intracranial Atherosclerosis
01/25
12/25
NCT06419088: Effect of Preoperative Individualized Education on Anxiety and Recovery.

Recruiting
N/A
156
RoW
Preoperative individualized education
Fujian Medical University Union Hospital
Education
12/24
12/25
NCT04718272: Safety and Feasibility of the Application of Thoracic Puncture Tube After Pulmonary Lobectomy

Recruiting
N/A
100
RoW
thoracic drainage management
Fujian Medical University Union Hospital
Chest Tubes, Pneumonectomy, Minimally Invasive Surgery
04/24
04/24
HeadSOAR, NCT06115707: Head Position After Endovascular Therapy

Recruiting
N/A
1332
RoW
The lying flat (0°-10°) head position for 72 hours, The The head elevation (30°-40°) position for 72 hours
Zhengzhou Yuan
Stroke, Acute, Endovascular Therapy
11/25
04/26
Hu, Crystal
No trials found

Download Options